Filing Details
- Accession Number:
- 0001235802-21-000111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-24 08:59:19
- Reporting Period:
- 2021-08-20
- Accepted Time:
- 2021-08-24 08:59:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427570 | Reshape Lifesciences Inc. | RSLS | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181166 | Thomas Stankovich | 1001 Calle Amanecer San Clemente CA 92673 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share | Acquisiton | 2021-08-20 | 15,000 | $3.22 | 17,613 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
